Nintedanib by Boehringer Approved in EU as Second-Line NSCLC Treatment
Lung Cancer, News
Drug maker Boehringer Ingelheim has announced that the European Commission granted Vargatef® (nintedanib) marketing approval in 28 EU countries. Together with docetaxel, it is indicated for the post-chemotherapy treatment of either locally ... Read more